Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 596

1.

Neonatal Presentation of Unremitting Inflammatory Bowel Disease.

Ebrahimi S MS, Khademi G MD, Jafari SA MD, Zaboli Nejad N MD, Norouzy A MD, Imani B MD.

Iran J Med Sci. 2018 May;43(3):328-331.

2.

Serologic and fecal markers to predict response to induction therapy in dogs with idiopathic inflammatory bowel disease.

Otoni CC, Heilmann RM, García-Sancho M, Sainz A, Ackermann MR, Suchodolski JS, Steiner JM, Jergens AE.

J Vet Intern Med. 2018 May;32(3):999-1008. doi: 10.1111/jvim.15123. Epub 2018 Apr 6.

3.

Diagnostic and clinical role of serum proteinase 3 antineutrophil cytoplasmic antibodies in inflammatory bowel disease.

Takedatsu H, Mitsuyama K, Fukunaga S, Yoshioka S, Yamauchi R, Mori A, Yamasaki H, Kuwaki K, Sakisaka H, Sakisaka S, Torimura T.

J Gastroenterol Hepatol. 2018 Mar 7. doi: 10.1111/jgh.14140. [Epub ahead of print]

PMID:
29514409
4.

Positivity of antineutrophil cytoplasmic antibodies in children: prevalence and etiologies.

Jerbi A, Feki S, Ben Ameur S, Hachicha H, Gargouri L, Kamoun T, Mahfoudh A, Hachicha M, Masmoudi H.

Ann Biol Clin (Paris). 2018 Jan 1;76(1):68-74. doi: 10.1684/abc.2017.1319.

PMID:
29386146
5.

Autoantibodies and Gastrointestinal Symptoms in Colombian Children with Juvenile Idiopathic Arthritis.

Gonzalez T, Malagon C, Guarnizo P, Mosquera AC, Chila-Moreno L, Romero-Sanchez C.

Curr Rheumatol Rev. 2018;14(2):163-171. doi: 10.2174/1573397114666180108110429.

PMID:
29308742
6.

Infliximab-Induced Lupus: A Case Report.

Magno Pereira V, Andrade C, Figueira R, Faria G, Jasmins L.

GE Port J Gastroenterol. 2017 Mar;24(2):84-88. doi: 10.1159/000450877. Epub 2016 Nov 19.

7.

Serology in autoimmune hepatitis: A clinical-practice approach.

Terziroli Beretta-Piccoli B, Mieli-Vergani G, Vergani D.

Eur J Intern Med. 2018 Feb;48:35-43. doi: 10.1016/j.ejim.2017.10.006. Epub 2017 Oct 19. Review.

PMID:
29056396
8.

Autoantibodies Against Glycoprotein 2 Isoforms in Pediatric Patients with Inflammatory Bowel Disease.

Röber N, Noß L, Goihl A, Reinhold D, Jahn J, de Laffolie J, Johannes W, Flemming GM, Roggenbuck D, Conrad K, Laass MW.

Inflamm Bowel Dis. 2017 Sep;23(9):1624-1636. doi: 10.1097/MIB.0000000000001159.

PMID:
28691939
9.

The value of serum antibodies in differentiating inflammatory bowel disease, predicting disease activity and disease course in the newly diagnosed patient.

Smids C, Horjus Talabur Horje CS, Groenen MJM, van Koolwijk EHM, Wahab PJ, van Lochem EG.

Scand J Gastroenterol. 2017 Oct;52(10):1104-1112. doi: 10.1080/00365521.2017.1344875. Epub 2017 Jun 29.

PMID:
28661185
10.

Clinical and Phenotypic Differences in Inflammatory Bowel Disease Among Arab and Jewish Children in Israel.

Rinawi F, Assa A, Bashir H, Peleg S, Shamir R.

Dig Dis Sci. 2017 Aug;62(8):2095-2101. doi: 10.1007/s10620-017-4623-x. Epub 2017 May 25.

PMID:
28547648
11.

Serologic testing of a panel of five antibodies in inflammatory bowel diseases: Diagnostic value and correlation with disease phenotype.

Wang ZZ, Shi K, Peng J.

Biomed Rep. 2017 Apr;6(4):401-410. doi: 10.3892/br.2017.860. Epub 2017 Feb 17.

12.

Non-granulomatous myositis in a patient with ulcerative colitis who showed symptoms resembling gastrocnemius myalgia syndrome.

Yamamoto M, Inoue M, Tachibana N, Tsuzaki K, Shibata Y, Hamano T.

Rinsho Shinkeigaku. 2017 Feb 25;57(2):71-76. doi: 10.5692/clinicalneurol.cn-000891. Epub 2017 Jan 28. Japanese.

PMID:
28132973
13.

Proteinase 3-antineutrophil cytoplasmic antibody-positive ulcerative colitis presenting with abducens neuropathy.

Kirito Y, Yamamoto D, Uchiyama T.

BMJ Case Rep. 2017 Jan 9;2017. pii: bcr2016218353. doi: 10.1136/bcr-2016-218353.

14.

Value of non-identified ANCA (non-PR3, non-MPO) in the diagnosis of granulomatosis with polyangiitis (Wegener's granulomatosis).

Givaudan M, Vandergheynst F, Stordeur P, Ocmant A, Melot C, Gangji V, Soyfoo MS.

Acta Clin Belg. 2017 Oct;72(5):313-317. doi: 10.1080/17843286.2016.1275374. Epub 2017 Jan 9.

PMID:
28067125
15.

Serologic antibodies in relation to outcome in postoperative Crohn's disease.

Hamilton AL, Kamm MA, De Cruz P, Wright EK, Selvaraj F, Princen F, Gorelik A, Liew D, Lawrance IC, Andrews JM, Bampton PA, Sparrow MP, Florin TH, Gibson PR, Debinski H, Gearry RB, Macrae FA, Leong RW, Kronborg I, Radford-Smith G, Selby W, Bell SJ, Brown SJ, Connell WR.

J Gastroenterol Hepatol. 2017 Jun;32(6):1195-1203. doi: 10.1111/jgh.13677.

PMID:
27976801
16.

Isolated Bilateral Gastrocnemius Myositis in Crohn Disease Successfully Treated with Adalimumab.

Vadala di Prampero S, Marino M, Toso F, Avellini C, Nguyen V, Sorrentino D.

Case Rep Gastroenterol. 2016 Nov 7;10(3):661-667. eCollection 2016 Sep-Dec.

17.

Serological markers in diagnosis of pediatric inflammatory bowel disease and as predictors for early tumor necrosis factor blocker therapy.

Olbjørn C, Cvancarova Småstuen M, Thiis-Evensen E, Nakstad B, Vatn MH, Perminow G.

Scand J Gastroenterol. 2017 Apr;52(4):414-419. doi: 10.1080/00365521.2016.1259653. Epub 2016 Nov 25.

PMID:
27887202
18.

Development of an indirect immunofluorescence based assay for diagnosis of ulcerative colitis in Indian population.

Rodrigues AV, Puri CP, Bhanushali PB, Shukla KK, Roychoudhury S, Badgujar SB.

Immunol Lett. 2017 Jan;181:20-25. doi: 10.1016/j.imlet.2016.11.008. Epub 2016 Nov 11.

PMID:
27845152
20.

Diagnosing ANCA-associated vasculitis in ANCA positive patients: A retrospective analysis on the role of clinical symptoms and the ANCA titre.

Houben E, Bax WA, van Dam B, Slieker WA, Verhave G, Frerichs FC, van Eijk IC, Boersma WG, de Kuyper GT, Penne EL.

Medicine (Baltimore). 2016 Oct;95(40):e5096.

Supplemental Content

Loading ...
Support Center